Japan sees poop as valuable resource for health research, business
Universities and companies are studying feces for medical breakthroughs
Metagen Therapeutics, a Yamagata-based startup, is trying to utilize aggregated intestinal bacteria data for drug discovery with Juntendo University and others.
TOKYO -- Human poop is attracting growing attention from Japanese medical researchers and health care businesses as a potentially valuable resource for developing new treatments or products.
In fecal transplant treatments, bacteria from a healthy person's intestines are transferred to those of a patient. In addition, new drugs have been developed and manufactured from donated human poop.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapterFind out more
Free access for everyone - Sep. 30